Christina Pressl

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer”.

First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3704

N/A

0.524DataRank · unranked

32 citations

Christina Pressl, Nagavarakishore Pillarsetty, Milan Grkovski, Shanu Modi, Komal Jhaveri +18 more

Interrogating an ICD-coded electronic health records database to characterize the epidemiology of prosopagnosia

Journal of Clinical and Translational Science(2020)10.1017/cts.2020.497

N/A

0.208DataRank · unranked

3 citations

Caroline S. Jiang, Joel Corrêa da Rosa, Maximilian Friedrich, Roger Vaughan, Winrich A. Freiwald +2 more

Selective Vulnerability of Layer 5a Corticostriatal Neurons in Huntington’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.24.538096

N/A

0DataRank · unranked

11 citations

Kärt Mätlik, Laura Kus, Paul Darnell, Ji‐Dung Luo, Matthew R. Paul +7 more

Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer

(2023)10.1158/1078-0432.c.6529761.v1

N/A

0DataRank · unranked

0 citations

Christina Pressl, Nagavarakishore Pillarsetty, Milan Grkovski, Shanu Modi, Komal Jhaveri +18 more

Selective vulnerability of layer 5a corticostriatal neurons in Huntington’s disease

Neuron(2024)10.1016/j.neuron.2023.12.009

N/A

0DataRank · unranked

87 citations

Kärt Mätlik, Laura Kus, Paul Darnell, Ji‐Dung Luo, Matthew R. Paul +7 more